Method of inducing formation of kidney epithelia from mesenchymal precursors
Patent Number: 6423681
Date of First Priority Issue: Tuesday May 4th, 1999
Date Issued: Tuesday July 23rd, 2002
Assignee: The Trustees of Columbia University in the City of New York (New York, NY)
Inventors: Barasch, Jonathan M. (New York, NY); Oliver, Juan A. (New York, NY); Yang, Jun (New York, NY)
From Class: Differentiation
Comments: No comments
This patent teaches how to induce formation of new kidney cells in vivo through the administration of ligands of gp130 such as LIF.
This is one of the few patents that covers administration of therapies systemically that induce generation of new cells by stimulation of endogenous stem cells.
This patent is in line with the approach of Transition Therapeutics for generation of new islets, and Stem Cell Therapeutics for generation of new neurons.
View this patent on the USPTO website.
Added to StemCellPatents.com on Monday October 16th, 2006
Social & Bookmarking:
Add Comment
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.